1,337
Views
78
CrossRef citations to date
0
Altmetric
Research Paper

Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes

, &
Pages 50-60 | Received 30 Aug 2011, Accepted 28 Nov 2011, Published online: 01 Jan 2012

References

  • Castino R, Demoz M, Isidoro C. Destination ‘lysosome’: a target organelle for tumour cell killing?. J Mol Recognit 2003; 16:337 - 348; PMID: 14523947; http://dx.doi.org/10.1002/jmr.643
  • Kirkegaard T, Jaattela M. Lysosomal involvement in cell death and cancer. Biochim Biophys Acta 2009; 1793:746 - 754; PMID: 18948147; http://dx.doi.org/10.1016/j.bbamcr.2008.09.008
  • Turk B, Turk V. Lysosomes as “suicide bags” in cell death: myth or reality?. J Biol Chem 2009; 284:21783 - 21787; PMID: 19473965; http://dx.doi.org/10.1074/jbc.R109.023820
  • Johansson AC, Appelqvist H, Nilsson C, Kagedal K, Roberg K, Ollinger K. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 2010; 15:527 - 540; PMID: 20077016; http://dx.doi.org/10.1007/s10495-009-0452-5
  • Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003; 197:1323 - 1334; PMID: 12756268; http://dx.doi.org/10.1084/jem.20021952
  • Roberg K, Ollinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 1998; 152:1151 - 1156; PMID: 9588882
  • Roberg K, Kagedal K, Ollinger K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 2002; 161:89 - 96; PMID: 12107093; http://dx.doi.org/10.1016/S0002-9440(10)64160-0
  • Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008; 27:6434 - 6451; PMID: 18955971; http://dx.doi.org/10.1038/onc.2008.310
  • Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM, et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004; 279:3578 - 3587; PMID: 14581476; http://dx.doi.org/10.1074/jbc.M308347200
  • Bidère N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 2003; 278:31401 - 31411; PMID: 12782632; http://dx.doi.org/10.1074/jbc.M301911200
  • Agostinelli E, Tempera G, Dalla Vedova L, Condello M, Arancia G. MDL 72527 and spermine oxidation products induce a lysosomotropic effect and mitochondrial alterations in tumour cells. Biochem Soc Trans 2007; 35:343 - 348; PMID: 17371275; http://dx.doi.org/10.1042/BST0350343
  • Nakashima S, Hiraku Y, Tada-Oikawa S, Hishita T, Gabazza EC, Tamaki S, et al. Vacuolar H+-ATPase inhibitor induces apoptosis via lysosomal dysfunction in the human gastric cancer cell line MKN-1. J Biochem 2003; 134:359 - 364; PMID: 14561721; http://dx.doi.org/10.1093/jb/mvg153
  • Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 2002; 283:G947 - G956; PMID: 12223355
  • Werneburg NW, Guicciardi ME, Bronk SF, Kaufmann SH, Gores GJ. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J Biol Chem 2007; 282:28960 - 28970; PMID: 17686764; http://dx.doi.org/10.1074/jbc.M705671200
  • Schütze S, Machleidt T, Adam D, Schwandner R, Wiegmann K, Kruse ML, et al. Inhibition of receptor internalization by monodansylcadaverine selectively blocks p55 tumor necrosis factor receptor death domain signaling. J Biol Chem 1999; 274:10203 - 10212; PMID: 10187805; http://dx.doi.org/10.1074/jbc.274.15.10203
  • Dumitru CA, Sandalcioglu IE, Wagner M, Weller M, Gulbins E. Lysosomal ceramide mediates gemcitabine-induced death of glioma cells. J Mol Med 2009; 87:1123 - 1132; PMID: 19763526; http://dx.doi.org/10.1007/s00109-009-0514-8
  • Kågedal K, Zhao M, Svensson I, Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 2001; 359:335 - 343; PMID: 11583579; http://dx.doi.org/10.1042/0264-6021:3590335
  • Heinrich M, Wickel M, Schneider-Brachert W, Sandberg C, Gahr J, Schwandner R, et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 1999; 18:5252 - 5263; PMID: 10508159; http://dx.doi.org/10.1093/emboj/18.19.5252
  • Larrick JW, Cresswell P. Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct 1979; 11:579 - 586; PMID: 232525; http://dx.doi.org/10.1002/jss.400110415
  • Renau-Piqueras J, Miragall F, Cervera J. Endocytosis of cationized ferritin in human peripheral blood by resting T-lymphocytes. Cell Tissue Res 1985; 240:743 - 746; PMID: 3874694; http://dx.doi.org/10.1007/BF00216363
  • Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T, et al. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 2004; 43:5618 - 5628; PMID: 15134436; http://dx.doi.org/10.1021/bi035802w
  • Li X, Ding L, Xu Y, Wang Y, Ping Q. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 2009; 373:116 - 123; PMID: 19429296; http://dx.doi.org/10.1016/j.ijpharm.2009.01.023
  • Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int J Pharm 2007; 329:94 - 102; PMID: 16997518; http://dx.doi.org/10.1016/j.ijpharm.2006.08.039
  • Hong M, Zhu S, Jiang Y, Tang G, Pei Y. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release 2009; 133:96 - 102; PMID: 18840485; http://dx.doi.org/10.1016/j.jconrel.2008.09.005
  • Heuser J, Kirchhausen T. Deep-etch views of clathrin assemblies. J Ultrastruct Res 1985; 92:1 - 27; PMID: 2870198; http://dx.doi.org/10.1016/0889-1605(85)90123-5
  • Enoch HG, Strittmatter P. Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. Proc Natl Acad Sci USA 1979; 76:145 - 149; PMID: 34148; http://dx.doi.org/10.1073/pnas.76.1.145
  • Ishida T, Iden DL, Allen TM. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett 1999; 460:129 - 133; PMID: 10571074; http://dx.doi.org/10.1016/S0014-5793(99)01320-4
  • McIntyre JC, Sleight RG. Fluorescence assay for phospholipid membrane asymmetry. Biochemistry 1991; 30:11819 - 11827; PMID: 1751498; http://dx.doi.org/10.1021/bi00115a012
  • Olsson GM, Rungby J, Rundquist I, Brunk UT. Evaluation of lysosomal stability in living cultured macrophages by cytofluorometry. Effect of silver lactate and hypotonic conditions. Virchows Arch B Cell Pathol Incl Mol Pathol 1989; 56:263 - 269; PMID: 2565621; http://dx.doi.org/10.1007/BF02890025
  • Khazanov E, Priev A, Shillemans JP, Barenholz Y. Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application. Langmuir 2008; 24:6965 - 6980; PMID: 18512883; http://dx.doi.org/10.1021/la800207z
  • Shabbits JA, Mayer LD. Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro. Biochim Biophys Acta 2003; 1612:98 - 106; PMID: 12729935; http://dx.doi.org/10.1016/S0005-2736(03)00108-1
  • Radin NS. Killing cancer cells by poly-drug elevation of ceramide levels: a hypothesis whose time has come?. Eur J Biochem 2001; 268:193 - 204; PMID: 11168352; http://dx.doi.org/10.1046/j.1432-1033.2001.01845.x
  • Stover T, Kester M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 2003; 307:468 - 475; PMID: 12975495; http://dx.doi.org/10.1124/jpet.103.054056
  • Stover TC, Sharma A, Robertson GP, Kester M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin Cancer Res 2005; 11:3465 - 3474; PMID: 15867249; http://dx.doi.org/10.1158/1078-0432.CCR-04-1770
  • Siskind LJ, Colombini M. The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J Biol Chem 2000; 275:38640 - 38644; PMID: 11027675; http://dx.doi.org/10.1074/jbc.C000587200
  • Boddapati SV, D'Souza GG, Erdogan S, Torchilin VP, Weissig V. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett 2008; 8:2559 - 2563; PMID: 18611058; http://dx.doi.org/10.1021/nl801908y
  • Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184:39 - 51; PMID: 7622868; http://dx.doi.org/10.1016/0022-1759(95)00072-I
  • Zdolsek J, Zhang H, Roberg K, Brunk U. H2O2-mediated damage to lysosomal membranes of J-774 cells. Free Radic Res Commun 1993; 18:71 - 85; PMID: 8386686; http://dx.doi.org/10.3109/10715769309147344

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.